Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Memesto Wearable Repetitive Message and Music Therapy Device Music Therapy Device That Senses and Reduces Agitation in People With AD, [NA]

View source ↗

Summary

The study of the Memesto wearable device for reducing agitation in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memesto Wearable Repetitive Message and Music Therapy Device

Snippet

Sponsor: Edgewater Safety Systems, Inc. | Conditions: Alzheimer's Disease | NA | Status: COMPLETED